BEAM THERAPEUTICS INC's ticker is BEAM and the CUSIP is 07373V105. A total of 214 filers reported holding BEAM THERAPEUTICS INC in Q2 2024. The put-call ratio across all filers is 0.82 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $24,589,062 | +15.9% | 1,049,360 | +63.5% | 0.01% | 0.0% |
| Q1 2024 | $21,207,088 | +37.4% | 641,861 | +13.2% | 0.01% | +20.0% |
| Q4 2023 | $15,431,556 | +53.9% | 566,858 | +35.9% | 0.01% | +66.7% |
| Q3 2023 | $10,028,995 | +10.4% | 417,007 | +46.5% | 0.00% | 0.0% |
| Q2 2023 | $9,088,017 | +64.5% | 284,626 | +57.8% | 0.00% | +50.0% |
| Q1 2023 | $5,522,960 | +113401.0% | 180,371 | +45.0% | 0.00% | +100.0% |
| Q4 2022 | $4,866 | -99.3% | 124,425 | +765.6% | 0.00% | – |
| Q3 2022 | $685,000 | -2.4% | 14,375 | -20.7% | 0.00% | – |
| Q2 2022 | $702,000 | -34.0% | 18,129 | -2.4% | 0.00% | – |
| Q1 2022 | $1,064,000 | +25.2% | 18,572 | +74.2% | 0.00% | – |
| Q4 2021 | $850,000 | -5.8% | 10,662 | +2.8% | 0.00% | – |
| Q3 2021 | $902,000 | +27.9% | 10,367 | +89.1% | 0.00% | – |
| Q2 2021 | $705,000 | +60.2% | 5,481 | -0.3% | 0.00% | – |
| Q1 2021 | $440,000 | – | 5,499 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MWG Management Ltd. | 2,346,934 | $56,443,763 | 54.70% |
| HSG Holding Ltd | 796,089 | $19,145,940 | 2.05% |
| Redmile Group, LLC | 1,469,725 | $35,346,886 | 1.68% |
| ARK Investment Management | 8,783,891 | $211,252,590 | 1.62% |
| Casdin Capital, LLC | 570,000 | $13,708,500 | 1.52% |
| Deep Track Capital, LP | 1,015,641 | $24,426,166 | 0.94% |
| Yiheng Capital Management, L.P. | 560,500 | $13,480,025 | 0.69% |
| Temasek Holdings (Private) Ltd | 4,317,789 | $103,842,825 | 0.62% |
| FARALLON CAPITAL MANAGEMENT LLC | 4,481,839 | $107,788,228 | 0.50% |
| Alphabet Inc. | 321,604 | $7,734,576 | 0.50% |